YU39004B - Process for preparing new xanthine derivatives - Google Patents

Process for preparing new xanthine derivatives

Info

Publication number
YU39004B
YU39004B YU03234/75A YU323475A YU39004B YU 39004 B YU39004 B YU 39004B YU 03234/75 A YU03234/75 A YU 03234/75A YU 323475 A YU323475 A YU 323475A YU 39004 B YU39004 B YU 39004B
Authority
YU
Yugoslavia
Prior art keywords
xanthine derivatives
preparing new
new xanthine
preparing
derivatives
Prior art date
Application number
YU03234/75A
Other languages
English (en)
Other versions
YU323475A (en
Inventor
W Konz
R Reichl
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of YU323475A publication Critical patent/YU323475A/xx
Publication of YU39004B publication Critical patent/YU39004B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU03234/75A 1974-12-21 1975-12-18 Process for preparing new xanthine derivatives YU39004B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (2)

Publication Number Publication Date
YU323475A YU323475A (en) 1982-08-31
YU39004B true YU39004B (en) 1983-12-31

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
YU03234/75A YU39004B (en) 1974-12-21 1975-12-18 Process for preparing new xanthine derivatives

Country Status (31)

Country Link
US (1) US3998953A (xx)
JP (1) JPS5188995A (xx)
AT (1) AT341540B (xx)
AU (1) AU501889B2 (xx)
BE (1) BE836898A (xx)
BG (1) BG25518A3 (xx)
CA (1) CA1036159A (xx)
CH (1) CH628346A5 (xx)
CS (1) CS191289B2 (xx)
DD (1) DD124984A5 (xx)
DE (1) DE2460929A1 (xx)
DK (1) DK137677C (xx)
ES (2) ES443738A1 (xx)
FI (1) FI62089C (xx)
FR (1) FR2294706A1 (xx)
GB (1) GB1517710A (xx)
GR (1) GR59204B (xx)
HU (1) HU174673B (xx)
IE (1) IE43208B1 (xx)
IL (1) IL48697A (xx)
LU (1) LU73972A1 (xx)
NL (1) NL7514837A (xx)
NO (1) NO144928C (xx)
NZ (1) NZ179599A (xx)
PH (1) PH11810A (xx)
PL (1) PL99165B1 (xx)
RO (1) RO68381A (xx)
SE (1) SE420493B (xx)
SU (1) SU603340A3 (xx)
YU (1) YU39004B (xx)
ZA (1) ZA757865B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (en) * 1997-12-17 1999-06-24 University Of South Florida Adenosine receptor antagonists with improved bioactivity
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (xx) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (xx) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
AU8754775A (en) 1977-06-23
DK571875A (da) 1976-06-22
FI62089C (fi) 1982-11-10
ATA904575A (de) 1977-06-15
GR59204B (en) 1977-11-26
CA1036159A (en) 1978-08-08
NZ179599A (en) 1978-03-06
FR2294706A1 (fr) 1976-07-16
IL48697A (en) 1979-07-25
IL48697A0 (en) 1976-02-29
CH628346A5 (de) 1982-02-26
HU174673B (hu) 1980-03-28
DD124984A5 (xx) 1977-03-23
RO68381A (ro) 1982-02-26
SE7514477L (sv) 1976-06-22
US3998953A (en) 1976-12-21
ES443738A1 (es) 1977-04-16
PH11810A (en) 1978-07-10
BE836898A (fr) 1976-06-21
BG25518A3 (en) 1978-10-10
ZA757865B (en) 1977-08-31
DK137677C (da) 1978-09-25
DK137677B (da) 1978-04-17
IE43208B1 (en) 1981-01-14
LU73972A1 (xx) 1977-02-15
IE43208L (en) 1976-06-21
SE420493B (sv) 1981-10-12
SU603340A3 (ru) 1978-04-15
NL7514837A (nl) 1976-06-23
FR2294706B1 (xx) 1978-12-01
AT341540B (de) 1978-02-10
NO144928B (no) 1981-08-31
DE2460929C2 (xx) 1987-12-17
FI62089B (fi) 1982-07-30
PL99165B1 (pl) 1978-06-30
AU501889B2 (en) 1979-07-05
NO754317L (xx) 1976-06-22
DE2460929A1 (de) 1976-06-24
FI753543A (xx) 1976-06-22
JPS5188995A (xx) 1976-08-04
YU323475A (en) 1982-08-31
GB1517710A (en) 1978-07-12
CS191289B2 (en) 1979-06-29
ES451457A1 (es) 1977-10-01
NO144928C (no) 1981-12-09

Similar Documents

Publication Publication Date Title
YU37157B (en) Process for preparing 1-z3-(naphth-1-yloxy)-2-hydroxy-propylc-piperazine derivatives
HU173590B (hu) Sposob poluchenija proizvodnykh d-6-metil-8-tiometil-ehrgolina
HU173739B (hu) Sposob poluchenija proizvodnykh tienotiazina
YU39113B (en) Process for preparing 2-arylamino-2-imidazoline derivatives
HU172431B (hu) Sposob poluchenija proizvodnykh fenola
HU174066B (hu) Sposob poluchenija geterociklicheski zamehhjonnykh proizvodnykh mocheviny
HU172493B (hu) Sposob poluchenija proizvodnykh tienobenzodiazepina
HU173751B (hu) Sposob poluchenija novykh proizvodnykh rifamicina
HU173740B (hu) Sposob poluchenija proizvodnykh aza-digidro-prostaglandina
HU174348B (hu) Sposob poluchenija proizvodnykh 13-tia-prostaglandinov
YU323475A (en) Process for preparing new xanthine derivatives
HU172537B (hu) Sposob poluchenija novykh proizvodnykh alkanolaminov
HU174300B (hu) Sposob poluchenija proizvodnykh 1-acil-4-/o-galofenil/-tiosemikarbazida
HU172146B (hu) Sposob poluchenija proizvodnykh cinnolina
HU171325B (hu) Sposob poluchenija 2-amino-2-imidazolina
HU171206B (hu) Sposob poluchenija novykh proizvodnykh fenil-piridil-allilamina
YU107875A (en) Process for preparing indolinoquinolyzine derivatives
YU39338B (en) Process for preparing indolo-quinolizisdine derivatives
YU157375A (en) Process for preparing new ergopetine derivatives
YU40449B (en) Process for obtaining new dianhydrodulcite derivatives
YU35891B (en) Process for obtaining 3-cephem-3-sulfonate derivatives
YU37350B (en) Process for obtaining new benzhydryloxy-alkylamine derivatives
YU162075A (en) Process for obtaining new thieno-pyridine derivatives
JPS5387355A (en) Process for preparing 55nitroimidazole derivative
HU173838B (hu) Sposob poluchenija novykh proizvodnykh metano-dibenzo-ciklogeptapirrola